Early serum HBV RNA combined with HBsAg response can predict HBeAg seroconversation in patients on Entecavir therapy (ClinicalTrials.gov (NCT03909191))

References

1. • Wu Y.
   • Wen J.
   • Tang G.
   • Zhang J.
   • Xin J.
   On-treatment HBV RNA dynamic predicts entecavir-induced HBeAg seroconversion in children with chronic hepatitis B.
   J Infect. 2021; 83 (NovPubMed PMID: 34474058. Epub 2021/09/03): 594-600
   View in Article

   • Scopus (5)
   • PubMed
   • Abstract
   • Full Text
   • Full Text PDF
   • Google Scholar

2. N.A. Terrault, N.H. Bzowej, K.-M. Chang, J.P. Hwang, M.M. Jonas, Murad6 M.H. AASLD Guidelines for Treatment of Chronic Hepatitis B. 2015.

   View in Article

   • Google Scholar
3. • Liu Y.
   • Xue J.
   • Liao W.
   • Yan H.
   • Liang X.
   Serum HBV RNA Dynamic and Drug Withdrawal Predictor Value in Patients With Chronic HBV Infection on Long-term Nucleos(t)ide Analogue (NA) Therapy.
   J Clin Gastroenterol. 2020; 54 (SepPubMed PMID: 32604147. Pubmed Central PMCID: PMC7458089. Epub 2020/07/01): e73-e82
   View in Article

   • Scopus (9)
   • PubMed
   • Crossref
   • Google Scholar
4. • Wang X.
   • Wang Z.
   • Chi X.
   • Wu R.
   • Jin Q.
   • Xu H.
   • et al.
   Efficacy of a combination of HBV RNA and HBeAg in predicting HBeAg seroconversion in patients treated with entecavir for 144 weeks.
   Int J Infect Dis. 2020; 99 (OctPubMed PMID: 32721532. Epub 2020/07/30): 171-178
   View in Article

   • Scopus (11)
   • PubMed
   • Abstract
   • Full Text
   • Full Text PDF
   • Google Scholar
5. • van Bommel F.
   • van Bommel A.
   • Krauel A.
   • Wat C.
   • Pavlovic V.
   • Yang L.
   • et al.
   Serum HBV RNA as a Predictor of Peginterferon Alfa-2a Response in Patients With HBeAg-Positive Chronic Hepatitis B.
   J Infect Dis. 2018; 218 (Aug 24PubMed PMID: 29741634. Epub 2018/05/10): 1066-1074
   View in Article

   • Scopus (50)
   • PubMed
   • Crossref
   • Google Scholar
6. • Jia W.
   • Zhu M.Q.
   • Xun QiQ.
   • Ting Wan.g
   • Xiao W.en
   • Chen Pe.i D.ong
   • et al.
   Serum hepatitis B virus RNA levels as a predictor of HBeAg seroconversion during treatment with peginterferon alfa-2a.
   Virology J. 2019; 16: 61
   View in Article

   • Scopus (9)
   • PubMed
   • Crossref
   • Google Scholar
7. • Liu Y.
   • Jiang M.
   • Xue J.
   • Yan H.
   • Liang X.
   Serum HBV RNA quantification: useful for monitoring natural history of chronic hepatitis B infection.
   BMC Gastroenterol. 2019; 19 (Apr 16PubMed PMID: 30991954. Pubmed Central PMCID: PMC6469196. Epub 2019/04/18): 53
   View in Article

   • Scopus (42)
   • PubMed
   • Crossref
   • Google Scholar
8. • Luo H.
   • Zhang X.X.
   • Cao L.H.
   • Tan N.
   • Kang Q.
   • Xi H.L.
   • et al.
   Serum hepatitis B virus RNA is a predictor of HBeAg seroconversion and virological response with entecavir treatment in chronic hepatitis B patients.
   World J Gastroenterol. 2019; 25 (Feb 14PubMed PMID: 30783375. Pubmed Central PMCID: PMC6378541. Epub 2019/02/21): 719-728
   View in Article

   • Scopus (10)
   • PubMed
   • Crossref
   • Google Scholar
9. • Liu S.
   • Zhou B.
   • Valdes J.D.
   • Sun J.
   • Guo H.
   Serum Hepatitis B Virus RNA: a New Potential Biomarker for Chronic Hepatitis B Virus Infection.
   Hepatology. 2019; 69 (AprPubMed PMID: 30362148. Pubmed Central PMCID: PMC6438723. Epub 2018/10/27): 1816-1827
   View in Article

   • Scopus (98)
   • PubMed
   • Crossref
   • Google Scholar
10. • Liu S.
    • Wu Y.
    • Deng R.
    • Shen S.
    • Fan R.
    • Peng J.
    • et al.
    Methodology-dependent performance of serum HBV RNA in predicting treatment outcomes in chronic hepatitis B patients.
    Antiviral Res. 2021; 189 (MayPubMed PMID: 33711337. Epub 2021/03/13)105037
    View in Article

    • Scopus (2)
    • Crossref
    • Google Scholar